0

527005

SHREEPAC

img img img img
No Data Available

SHREE PACETRONIX LTD. Share Price Update

As of the latest trading session, SHREE PACETRONIX LTD. share price is currently at ₹114.94, which is up by ₹8.13 from its previous closing. Today, the stock has fluctuated between ₹102.30 and ₹119.50. Over the past year, SHREE PACETRONIX LTD. has achieved a return of 60.18%. In the last month alone, the return has been -22.85%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SHREE PACETRONIX LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    39.30

  • P/E Ratio (TTM)

    15.77

  • Beta

    0.03

  • Book Value / share

    44.91

  • Return on equity

    5.54%

  • EPS (TTM)

    6.84

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.06

info icon alternate text

SHREE PACETRONIX LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 4.33
Operating Expense 4.18
Net Profit 0.06
Net Profit Margin (%) 1.38
Earnings Per Share (EPS) 0.17
EBITDA 0.46
Effective Tax Rate (%) 62.50
Particulars SEP 2025 (Values in Cr)
Revenue 6.59
Operating Expense 4.86
Net Profit 1.32
Net Profit Margin (%) 20.03
Earnings Per Share (EPS) 3.68
EBITDA 2.05
Effective Tax Rate (%) 25.00
Particulars JUN 2025 (Values in Cr)
Revenue 5.34
Operating Expense 4.47
Net Profit 0.67
Net Profit Margin (%) 12.54
Earnings Per Share (EPS) 1.86
EBITDA 1.18
Effective Tax Rate (%) 25.55
Particulars MAR 2025 (Values in Cr)
Revenue 4.28
Operating Expense 3.65
Net Profit 0.47
Net Profit Margin (%) 10.98
Earnings Per Share (EPS) 1.29
EBITDA 0.98
Effective Tax Rate (%) 29.23
Particulars DEC 2024 (Values in Cr)
Revenue 3.63
Operating Expense 3.81
Net Profit -0.11
Net Profit Margin (%) -3.03
Earnings Per Share (EPS) -0.32
EBITDA 0.12
Effective Tax Rate (%) 29.41
Particulars MAR 2025 (Values in Cr)
Revenue 16.80
Operating Expense 15.88
Net Profit 0.75
Net Profit Margin (%) 4.46
Earnings Per Share (EPS) 2.09
EBITDA 2.32
Effective Tax Rate (%) 27.88
Particulars MAR 2024 (Values in Cr)
Revenue 22.04
Operating Expense 17.55
Net Profit 3.36
Net Profit Margin (%) 15.24
Earnings Per Share (EPS) 9.33
EBITDA 5.80
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 20.19
Operating Expense 15.69
Net Profit 3.25
Net Profit Margin (%) 16.09
Earnings Per Share (EPS) 9.02
EBITDA 5.52
Effective Tax Rate (%) 29.34
Particulars MAR 2022 (Values in Cr)
Revenue 9.03
Operating Expense 8.20
Net Profit 0.65
Net Profit Margin (%) 7.19
Earnings Per Share (EPS) 1.81
EBITDA 1.66
Effective Tax Rate (%) 26.13
Particulars MAR 2021 (Values in Cr)
Revenue 7.56
Operating Expense 7.30
Net Profit 0.18
Net Profit Margin (%) 2.38
Earnings Per Share (EPS) 0.51
EBITDA 1.16
Effective Tax Rate (%) 41.93
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.29
ROE % 5.59
ROCE % 9.10
Total Debt to Total Equity 0.35
EBITDA Margin 14.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.21
ROE % 29.60
ROCE % 34.65
Total Debt to Total Equity 0.29
EBITDA Margin 27.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 26.88
ROE % 40.55
ROCE % 46.02
Total Debt to Total Equity 0.33
EBITDA Margin 27.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 17.82
ROE % 12.96
ROCE % 14.71
Total Debt to Total Equity 0.52
EBITDA Margin 20.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.65
ROE % 0.89
ROCE % 5.40
Total Debt to Total Equity 0.58
EBITDA Margin 13.10
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.64
ROE % 5.54
ROCE % 9.01
Total Debt to Total Equity 0.34
EBITDA Margin 13.93
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.55
ROE % 29.27
ROCE % 34.41
Total Debt to Total Equity 0.28
EBITDA Margin 26.72
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.22
ROE % 39.76
ROCE % 45.67
Total Debt to Total Equity 0.31
EBITDA Margin 27.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 18.19
ROE % 10.44
ROCE % 12.80
Total Debt to Total Equity 0.45
EBITDA Margin 18.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.38
ROE % 3.10
ROCE % 7.62
Total Debt to Total Equity 0.46
EBITDA Margin 15.34
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.11
Total Assets 23.04
Total Liabilities 23.04
Total Equity 13.78
Share Outstanding 0
Price to Book Ratio 1.61
Return on Assets (%) 3.25
Return on Capital (%) 3.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.80
Total Assets 21.74
Total Liabilities 21.74
Total Equity 13.03
Share Outstanding 0
Price to Book Ratio 4.15
Return on Assets (%) 15.44
Return on Capital (%) 19.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.84
Total Assets 16.54
Total Liabilities 16.54
Total Equity 9.67
Share Outstanding 0
Price to Book Ratio 3.59
Return on Assets (%) 19.70
Return on Capital (%) 27.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.43
Total Assets 12.17
Total Liabilities 12.17
Total Equity 6.41
Share Outstanding 0
Price to Book Ratio 1.12
Return on Assets (%) 6.41
Return on Capital (%) 8.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 10.97
Total Liabilities 10.97
Total Equity 5.63
Share Outstanding 0
Price to Book Ratio 0.71
Return on Assets (%) 0.48
Return on Capital (%) 0.6
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.10
Total Assets 23.03
Total Liabilities 23.03
Total Equity 13.90
Share Outstanding 0
Price to Book Ratio 1.61
Return on Assets (%) 3.26
Return on Capital (%) 3.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 21.81
Total Liabilities 21.81
Total Equity 13.15
Share Outstanding 0
Price to Book Ratio 4.15
Return on Assets (%) 15.39
Return on Capital (%) 19.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.83
Total Assets 16.60
Total Liabilities 16.60
Total Equity 9.79
Share Outstanding 0
Price to Book Ratio 3.59
Return on Assets (%) 19.55
Return on Capital (%) 27.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.57
Total Assets 12.04
Total Liabilities 12.04
Total Equity 6.54
Share Outstanding 0
Price to Book Ratio 1.12
Return on Assets (%) 5.41
Return on Capital (%) 6.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 10.69
Total Liabilities 10.69
Total Equity 5.89
Share Outstanding 0
Price to Book Ratio 0.71
Return on Assets (%) 1.71
Return on Capital (%) 2.13
Particulars MAR 2025 (Values in Cr)
Net Income 1.04
Cash from Operations 1.09
Cash from Investing -0.04
Cash from Financing 0.18
Net change in Cash 0.14
Free Cash Flow 1.80
Particulars MAR 2024 (Values in Cr)
Net Income 4.62
Cash from Operations 1.11
Cash from Investing -1.66
Cash from Financing 1.74
Net change in Cash 0.04
Free Cash Flow 2.49
Particulars MAR 2023 (Values in Cr)
Net Income 4.62
Cash from Operations 2.63
Cash from Investing -1.41
Cash from Financing -1.10
Net change in Cash -0.82
Free Cash Flow 3.87
Particulars MAR 2022 (Values in Cr)
Net Income 1.06
Cash from Operations 1.89
Cash from Investing -1.18
Cash from Financing -0.44
Net change in Cash 0.12
Free Cash Flow 2.29
Particulars MAR 2021 (Values in Cr)
Net Income 0.13
Cash from Operations 1.26
Cash from Investing -0.53
Cash from Financing -0.31
Net change in Cash 0.24
Free Cash Flow 2.02
Particulars MAR 2025 (Values in Cr)
Net Income 1.04
Cash from Operations 1.15
Cash from Investing -0.03
Cash from Financing 0.11
Net change in Cash 0.13
Free Cash Flow 1.86
Particulars MAR 2024 (Values in Cr)
Net Income 4.62
Cash from Operations 1.11
Cash from Investing -1.67
Cash from Financing 1.74
Net change in Cash 0.04
Free Cash Flow 2.49
Particulars MAR 2023 (Values in Cr)
Net Income 4.59
Cash from Operations 3.31
Cash from Investing -1.40
Cash from Financing -0.96
Net change in Cash 0.02
Free Cash Flow 4.53
Particulars MAR 2022 (Values in Cr)
Net Income 0.88
Cash from Operations 0.72
Cash from Investing -1.10
Cash from Financing -0.14
Net change in Cash -0.65
Free Cash Flow 1.12
Particulars MAR 2021 (Values in Cr)
Net Income 0.31
Cash from Operations 1.16
Cash from Investing -0.58
Cash from Financing -0.15
Net change in Cash 0.25
Free Cash Flow 1.83
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7492.85 59.31 11.85 107735.69 6017.95 8099.00
FORTIS MALAR HOSPITALS LIMITED 50.59 20.90 2.75 94.81 46.65 98.70
TRANSGENE BIOTEK LTD. 2.43 0.00 1.99 18.41 1.83 5.26
VIMTA LABS LTD. 412.95 30.34 5.38 1844.62 372.50 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7492.85 74.18 11.56 107735.69 6017.95 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 37.06 0.00 -10.76 27.68 28.34 57.48
KOVAI MEDICAL CENTER & HOSPITA 5106.00 23.69 4.69 5585.96 5049.80 6725.00

SHREE PACETRONIX LTD. shareholding pattern

Holding

74.06%
25.79%
0.13%
13.6%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SHREE PACETRONIX LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
106.95 -0.83 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 115.00
  • 26 Days 129.00
  • 10 Days 118.40
  • 50 Days 145.70
  • 12 Days 119.60
  • 100 Days 163.70
  • 20 Days 124.90
  • 200 Days 163.70
112.98 PIVOT

First Support

101.02

First Resistance

119.82

Second Support

94.18

Second Resistance

131.78

Third Support

82.22

Third Resistance

138.62

RSI

35.72

ADX

21.75

MACD

-9.34

Williams % R

-81.49

Commodity Channel Index (CCI)

-104.52

Date

2026-03-16

Week

2824.00

Same Day

10080.00

Month

2934.00

1 Year

0.04

3 Year

0.34

Over 1 Month

-22.85%

down

Over 1 Year

60.18%

down

Over 3 Months

-56.83%

down

Over 3 Years

3.61%

down

Over 6 Months

-48.06%

down

Over 5 Years

56.27%

down

SHREE PACETRONIX LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
24 Sep 2007 0.5 Final 26 Sep 2007 Equity shares

Top Gainers

SHREE PACETRONIX LTD. Share Price

Shree Pacetronix Limited, a leading manufacturer / exporter of Pacemakers, was incorporated in January 1988 as a Private Limited Company and converted into a Public Limited Company in 1993. It has a plant at Pithampur, Madhya Pradesh with installed capacity to produce 4800 pacemakers per annum.

Pacemakers are used to treat patients suffering mainly from heart conditions, such as heart failure and arrhythmias. These devices are implanted under patient's chest by cardiologist to deal with various indications and used for the treatment of heart medical conditions. Innovations such as longer-lasting batteries, advanced remote monitoring capabilities, and next-generation leadless and MRI-safe pacemakers are key pillars of the R&D agenda. These developments not only improve clinical outcomes but also align with evolving patient needs and healthcare provider expectations, allowing to maintain a competitive edge in the rapidly advancing pacemaker industry.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Shree Pacetronix Ltd?

Answer Field

Shree Pacetronix Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 106.95 as on Apr 02 2026 03:26 PM.

What is the Market Cap of Shree Pacetronix Ltd Share?

Answer Field

The market cap of Shree Pacetronix Ltd for NSE ₹ 0.00 & for BSE ₹ 39.30 as on Apr 02 2026 03:26 PM.

What is the 52 Week High and Low of Shree Pacetronix Ltd?

Answer Field

The 52 Week High and Low of Shree Pacetronix Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 283.15 and ₹ 61.11.

What is 1 year return for Shree Pacetronix Ltd?

Answer Field

The 1 year returns on the stock has been 60.18%.

What is the P/E Ratio of Shree Pacetronix Ltd Share?

Answer Field

As on Apr 02 2026 03:26 PM the price-to-earnings (PE) ratio for Shree Pacetronix Ltd share is 15.77.

What is the PB ratio of Shree Pacetronix Ltd Share?

Answer Field

As on Apr 02 2026 03:26 PM, the price-to-book (PB) ratio for Shree Pacetronix Ltd share is 44.91.

How to Buy Shree Pacetronix Ltd Share?

Answer Field

You can trade in Shree Pacetronix Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Pacetronix Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Pacetronix Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Pacetronix Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59